Hormonal

Plecanatide

Also known as: Trulance

FDA Approved
Share:

Key Facts: Plecanatide

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - CIC and IBS-C
Administration
Oral tablet with or without food
Typical Dose
Limited community data available
Frequency
See research protocols
Duration
Long-term / chronic use
Also Known As
Trulance

Mechanism of Action

Plecanatide is built as an analog of uroguanylin, a natural peptide your intestine already makes to manage fluid balance. It activates guanylate cyclase-C receptors on the gut lining, which raises cyclic GMP inside those cells. That triggers chloride and bicarbonate secretion into the intestine and blocks sodium reabsorption, so water is drawn into the bowel, softening stool and speeding transit. One proposed difference from linaclotide is that its activity is more strongly switched on in the slightly acidic environment of the upper small intestine, which the manufacturer argues may shape where it acts, though this is a positioning claim more than a proven clinical advantage. Like other GC-C agonists it is minimally absorbed and works locally.

Research Summary

Plecanatide has real, published phase 3 human data behind its approval. Randomized, double-blind, placebo-controlled trials in chronic idiopathic constipation showed that 3 mg once daily significantly improved stool frequency and consistency, straining, and abdominal symptoms versus placebo, and an integrated analysis of two phase 3 IBS-C trials reported similar benefits on the combined pain-plus-bowel-movement endpoint. It is generally well tolerated, and as with linaclotide the most common adverse event is diarrhea, which is the on-target effect taken too far. Head-to-head trials proving it is meaningfully better than linaclotide are limited, so the two are best thought of as broadly comparable GC-C agonists rather than one being clearly superior. The honest summary is an approved, evidence-backed drug whose main selling point over its predecessor is incremental rather than dramatic.

Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosing

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research Dosing

Scientific studies

FDA-approved dosing

Doses from Studies

Duration

Long-term / chronic use

Administration

Oral tablet with or without food

Timing & Administration

Best Time to Take

Morning or as directed

Follow recommended protocol

Food Recommendation

With or without food

Why This Timing?

Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Diarrhea (4-5%)
  • Nausea
  • CONTRAINDICATED in children <6 years
  • FDA approved (Trulance)

References

Research This Peptide Further

Frequently Asked Questions

What does Plecanatide do?

Plecanatide (brand name Trulance) is a 16-amino-acid peptide and a guanylate cyclase-C agonist, FDA-approved in January 2017 for chronic idiopathic constipation and later for IBS-C. It is essentially a close cousin of linaclotide, designed to mimic the body's own gut hormone uroguanylin, and it is taken as a 3 mg tablet once a day. Think of it as a second-generation version of the same idea, engineered to be a touch more pH-selective in the gut.

How does Plecanatide work?

Plecanatide is built as an analog of uroguanylin, a natural peptide your intestine already makes to manage fluid balance. It activates guanylate cyclase-C receptors on the gut lining, which raises cyclic GMP inside those cells. That triggers chloride and bicarbonate secretion into the intestine and blocks sodium reabsorption, so water is drawn into the bowel, softening stool and speeding transit. One proposed difference from linaclotide is that its activity is more strongly switched on in the slightly acidic environment of the upper small intestine, which the manufacturer argues may shape where it acts, though this is a positioning claim more than a proven clinical advantage. Like other GC-C agonists it is minimally absorbed and works locally.

Is Plecanatide FDA approved?

Yes, Plecanatide is FDA approved. FDA Approved - CIC and IBS-C

What are the side effects of Plecanatide?

Reported side effects include: Diarrhea (4-5%), Nausea, CONTRAINDICATED in children <6 years, FDA approved (Trulance). Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of Plecanatide?

Community-reported common dose: Limited community data available (See research protocols). Range: See research dosing. Administration: Oral tablet with or without food. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with Plecanatide or used in similar applications.

Oxytocin

FDA

Oxytocin is a 9-amino-acid hormone made in the hypothalamus, famous as the chemistry behind labor contractions, breastfeeding, and social bonding. As an injectable drug it is FDA-approved to induce labor and control postpartum bleeding, but the intranasal 'love hormone' versions sold for trust, anxiety, and autism are experimental and the human results are genuinely mixed. The hype runs well ahead of the evidence.

Hormonal

Gonadorelin

FDA

Gonadorelin is a synthetic copy of natural GnRH (gonadotropin-releasing hormone), a 10-amino-acid peptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) that tells the pituitary to release LH and FSH. It is FDA-approved for evaluating pituitary function and has historical use in inducing ovulation. In the peptide world it is mostly used off-label to keep the testes working during testosterone replacement, and the catch is that timing matters enormously: pulse it and you stimulate, give it continuously and you shut the system down.

Hormonal

Leuprolide

FDA

Leuprolide (brand name Lupron) is a synthetic GnRH agonist, a modified peptide about 20 times more potent than natural GnRH, and it is FDA-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The clever part is counterintuitive: it works by overstimulating the GnRH system so hard that the pituitary shuts down sex hormone production. It is a real, long-established prescription drug, not a research peptide, and it carries meaningful side effects from the low-hormone state it creates.

Hormonal

Desmopressin

FDA

Desmopressin (dDAVP) is a synthetic tweak of the natural hormone vasopressin, redesigned to keep the water-retaining effect while dropping most of the blood-pressure effect. It is a long-established FDA-approved drug used for central diabetes insipidus, bedwetting and nocturia, and certain bleeding disorders like von Willebrand disease and mild hemophilia A. This is settled medicine, not an experimental peptide, and its main real-world danger is straightforward: it can drop your blood sodium dangerously low if you drink too much fluid on it.

Hormonal

Octreotide

FDA

Octreotide is a synthetic eight-amino-acid mimic of the natural hormone somatostatin, the body's main 'off switch' for hormone secretion. It shuts down excess growth hormone, so it is a frontline FDA-approved drug for acromegaly, and it also tames the flushing and diarrhea of hormone-secreting carcinoid and other neuroendocrine tumors. This is real, approved medicine with decades of clinical data behind it, sold as Sandostatin (injectable, since 1988), Sandostatin LAR (monthly depot), and Mycapssa (oral capsule, approved 2020).

Hormonal

Lanreotide

FDA

Lanreotide is an eight-amino-acid somatostatin analog, a close cousin of octreotide, given as a long-acting deep-injection gel (Somatuline Depot/Autogel) usually once a month. It is FDA-approved for acromegaly and for gastroenteropancreatic neuroendocrine tumors, and it carries an approval for carcinoid syndrome. It is established prescription medicine, not an experimental compound.

Hormonal

Want updates on Plecanatide research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.